Atlas FDA

INTERSTIM THERAPY SYSTEM

FDA premarket approval P080025/S085 · decided 2015-02-10

Approval details

PMA number
P080025
Supplement
S085
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INTERSTIM THERAPY SYSTEM
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2015-01-12
Decision date
2015-02-10
Days to decision
29 days
Decision code
OK30
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
SUPPLIER FACILITY CHANGE AND A CHANGE IN DOPING MATERIAL APPLICATION PROCESS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23